Cutting-Edge Technologies in Lung Cancer Testing
Key Growth Drivers and Opportunities
Rising Demand for Personalized Treatment: Increasing demand for personal treatment is significantly increasing the development of lung cancer diagnostic test market, as it requires accurate and wide diagnostic equipment to identify specific genetic mutations, biomarkers and cancer sub-types. Personal remedies, such as targeted drugs and immunotherapy, have greatly rely on accurate clinical consequences for tailor treatment schemes for individual patients. This has increased adopting advanced clinical techniques such as liquid biopsy, next generation sequencing (NGS), and molecular testing. Since healthcare provider and patients want more effective, less aggressive and sewn treatment approaches, the demand for high-collective clinical trials continues to promote market expansion.
Challenges
Lung cancer diagnostic test market faces many borders that can obstruct its growth and access. High costs associated with advanced clinical technologies such as PET scans, liquid biopsy and next generation sequencing make them less cheap in countries with less and moderate income. Additionally, delayed diagnosis in delayed diagnosis due to limited infrastructure, lack of efficient health professionals, and lack of awareness in the reduction of available tests. In some clinical methods, false positive or negative can also cause incorrect diagnosis, affecting the consequences of treatment. Regulatory barriers and variability in testing accuracy further limited widely adopting innovative clinical equipment in clinical settings.
Innovation and Expansion
An Innovative Lung Cancer Screening Trial for High-Risk Individuals has been launched by the EQUAL Study
In May 2025, Researchers at the Dana-Farber Cancer Institute have begun testing a new, in-house blood test in an effort to screen for lung cancer and identify those who are at a higher risk of developing the disease even if they have never used tobacco. As lung cancer is becoming more common in younger people and among Asian or Hispanic/Latinx people who have never used tobacco, the team, led by the principal investigator and thoracic oncologist, associate director of Dana-Farber's Cancer Care Equity Program, designed the study.
Epidermal growth factor receptor (EGFR) gene mutations can be common in the Asian and Hispanic/Latinx populations, which is the subject of the EQUAL (EGFR ctDNA Quantitative Assessment for Lung Cancer screening in Asian and Latinx populations) study. Possessing this mutation increases the risk of lung cancer because EGFR type mutations are linked to the illness. Additionally, the number of cancer diagnoses among Asian or Hispanic/Latinx individuals is increasing at a faster rate.
The LuNGS Alliance has launched a Free NGS Biomarker Screening Program for Lung Cancer
In March 2025, For patients with lung cancer throughout India, the Cancer Research and Statistics Foundation (CRSF)-led LuNGS Alliance has announced free lung NGS biomarker testing. AstraZeneca, Pfizer, and Roche support this program, and 4baseCare is the official lab partner. The initiative's goal is to raise awareness of precision oncology as a crucial, easily accessible, and reasonably priced therapy option for lung cancer.
4baseCare's TARGT First Solid test provides a thorough examination of 72 frequently mutated genes, revealing actionable biomarkers that allow for individualized treatment regimens based on each patient's own genetic profile. The test finds mutations that match FDA and NCCN-approved medications, enabling oncologists to offer more individualized, potent treatments that can greatly enhance patient outcomes.
Inventive Sparks, Expanding Markets
The key players operating in the lung cancer diagnostic test market includes Abbott, Illumina, Inc., Thermo Fischer Scientific, QIAGEN, Quest Diagnostics Incorporated, NeoGenomics, NanoString, Myriad Genetics Inc., F. Hoffmann-La Roche Ltd, Danaher, Agilent Technologies, Inc., AstraZeneca, Sanofi, and Janssen Pharmaceuticals, Inc.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
2 days ago
- UPI
Your heart could be aging faster than you are
The research team theorizes that telling folks their heart age might help spur them to healthier lifestyles and treatment. Photo by Adobe Stock/HealthDay July 31 (UPI) -- Researchers who have developed a new "heart age" calculator say many Americans have unhealthy hearts that are physiologically older than their chronological age, with men faring worse than women. The research team theorizes that telling folks their heart age might help spur them to healthier lifestyles and treatment. "Many people who should be on medicine to lower their risk for heart attack, stroke or heart failure are not on these medications," explained study senior author Dr. Sadiya Khan in a news release. "We hope this new heart age calculator will help support discussions about prevention and ultimately improve health for all people." The new heart age calculator, which is free to the public, is available online. Study findings were published Wednesday in JAMA Cardiology. Khan, a professor of cardiovascular epidemiology, and her colleagues at Northwestern University in Chicago, note that the calculator is based on the American Heart Association's PREVENT equations, which talk about a patient's heart risk in terms of percentages. For example, a doctor might use the equation to tell a patient, "8 out 10 people with your [cardiovascular] profile may have a heart event in the next 10 years." Khan's group hoped that expressing the heart's condition as an age might be easier for folks to grasp. To test the new heart age tool, they applied it to data on 14,000 nationally representative U.S. adults, ages 30 to 79, who participated in the National Health and Nutrition Examination Survey between 2011 and 2020. None of the participants had any prior history heart disease at the time of the analysis. In most cases, people's heart age was older than the number of candles on their birthday cake. For example, over the whole cohort, women had an average heart age of 55.4 years, compared to an average chronological age of 51.3, the study found. The news was worse for men: Their average heart age was 56.7, compared to an average chronological age of 49.7. Certain demographic factors were in play, Khan's group noted. Among men, for example, nearly a third of those who had achieved a high school education or less had a heart age that was 10 years or more older than their chronological age, the study found. For men and women alike, being Black or Hispanic also tended to widen the gap between heart age and chronological age. "Black men had a heart age 8.5 years older than their actual age, compared to 7.9 years for Hispanic men, 6.7 years for Asian men and 6.4 years for white men," a Northwestern University news release said. "The gaps were 6.2 years for Black women, 4.8 years for Hispanic women, 3.7 years for white women and 2.8 years for Asian women." The key to shrinking these health gaps is prevention, Khan said. She hopes the new tool can help motivate people. "We hope this tool helps doctors and patients discuss risk for heart disease more effectively so we can better inform what therapies can prevent heart attacks, stroke or heart failure events from ever happening," Khan said in the news release. "The important thing is that we have very good options available in our toolbox to help slow that aging down if we can identify it," she added. "This may be even more important in younger people who don't often think about their risk for heart disease." More information Find out more about keeping your heart healthy at the American Heart Association. Copyright © 2025 HealthDay. All rights reserved.
Yahoo
2 days ago
- Yahoo
Officials forced to shut down popular beach due to concerning infestation: 'This decision comes after extensive consultation'
Officials forced to shut down popular beach due to concerning infestation: 'This decision comes after extensive consultation' Warmer temperatures mean more bugs, like disease-carrying mosquitoes and ticks. In Bridgeport, Connecticut, Asian longhorned ticks –– among other tick species –– established themselves on Pleasure Beach and prompted officials to close the area, the Bridgeport Daily Voice reported. What's happening? Multiple tick species were discovered on the beach, including the invasive and disease-carrying Asian longhorned tick. The Asian longhorned tick is spreading across the Northeast, according to the Bridgeport Daily Voice, and its infestation of Pleasure Beach shut down the summertime destination. "We regret to inform everyone that Pleasure Beach will remain closed to the public for the 2025 summer season. This decision comes after extensive consultation with state environmental experts," the city of Bridgeport wrote on Facebook. Along with ticks, however, officials observed an increase in protected Audubon bird species nesting on the beach. These birds reinforced the decision to close Pleasure Beach, the city of Bridgeport explained, and caused experts to reevaluate human activity in the area. Why are ticks concerning? Like other ticks, the Asian longhorned tick can carry diseases such as Lyme disease, anaplasmosis, and babesiosis, according to the Bridgeport Daily Voice. It can also spread Ehrlichia chaffeensis, bacteria that causes the potentially life-threatening disease ehrlichiosis. The species presents concerns due to its ability to reproduce asexually, too. A single female Asian longhorned tick can produce an entire colony, the Bridgeport Daily Voice explained, allowing it to rapidly expand its numbers. Additionally, disease-carrying ticks and insects are becoming more prevalent as warmer temperatures enable them to propagate to more areas, such as Pleasure Beach. Cases of Lyme disease have skyrocketed, and ticks may infect as many as 625,000 people every year, USA Today warned. Do you worry about the longevity of EV batteries? For sure Not really Not at all I've never thought about it Click your choice to see results and speak your mind. What's being done about disease-carrying ticks? To address the infestation at Pleasure Beach, officials announced the city of Bridgeport "will be conducting a series of treatment and containment efforts throughout the area." These efforts will promote public health and environmental safety, according to the city. The city also stated it will monitor conditions and open the beach once it is safe to do so, hopefully next summer. Until then, individuals can take actions to prevent tick-borne diseases by reducing their exposure to ticks. Wearing long clothing and applying insect repellent can keep the disease-carrying arachnids off of you in tick-prone places like grassy or wooded areas, the CDC recommended. While rising temperatures increase ticks and disease, addressing the root of the problem –– like polluting energy sources –– can help stop their spread. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
Boston Globe
2 days ago
- Boston Globe
Canceled HIV research in R.I. is reinstated, but fears persist about DEI crackdown
The order from US District Judge William Young in Massachusetts was narrow, reinstating nearly 900 grants awarded to the plaintiffs, not all of the thousands of grants canceled by NIH so far this year. Young called DEI an 'undefined enemy‚" and said the Trump administration's 'blacklisting' of certain topics 'has absolutely nothing to do with the promotion of science or research.' Get Rhode Island News Alerts Sign up to get breaking news and interesting stories from Rhode Island in your inbox each weekday. Enter Email Sign Up The Trump administration is appealing the ruling, and Advertisement 'We feel like we're tippy-toeing around,' said Nunn, who leads the Rhode Island Public Health Institute. 'The backbone of the field is steadfast pursuit of the truth. People are trying to find workarounds where they don't have to compromise the integrity of their science.' Advertisement Nunn said she renewed her membership to the American Public Health Association in order to ensure she'd be included in the lawsuit. Despite DEI concerns, she plans to continue enrolling gay Black and Hispanic men in her study, which will include 300 patients in Rhode Island, Mississippi, and Washington, D.C. Black and Hispanic men who have sex with other men contract HIV at The study was just getting underway, with 20 patients enrolled, when the work was shut down by the NIH in March. While Nunn's clinic in Providence did not do any layoffs, the clinic in Mississippi — Express Personal Health — shut down, and the D.C. clinic laid off staff. The four-month funding flip-flop could delay the results of the study by two years, Nunn said, depending on how quickly the researchers can rehire and train new staff. The researchers will also need to find a new clinic in Mississippi. The patients — 100 each in Rhode Island, Mississippi, and D.C. — will then be followed for a year as they take Pre-Exposure Prophylaxis, or PrEP, to The protocol that's being studied is the use of a patient navigator for 'aggressive case management.' That person will help the patient navigate costs, insurance, transportation to the clinic, dealing with homophobia and other barriers to staying on PrEP, which can be taken as a pill or a shot. The study's delay means 'the science is aging on the vine,' Nunn said, as new HIV prevention drugs are rolled out. 'The very thing that we're studying might very well be obsolete by the time we're able to reenroll all of this.' Advertisement Dr. Amy Nunn, executive director of the Rhode Island Public Health Institute, in a patient room at Open Door Health, an HIV clinic in Providence, R.I. Patients will be seen here for her HIV study that has been reinstated following a lawsuit against the Trump administration. Jonathan Wiggs/Globe Staff The hundreds of reinstated grants include titles that reference race and gender, such as a study of cervical cancer screening rates in Latina women, alcohol use among transgender youth, aggressive breast cancer rates in Black and Latina women, and multiple HIV/AIDs studies involving LGBTQ patients. 'Many of these grants got swept up almost incidentally by the particular language that they used,' said Peter Lurie, the president of the Center of Science in the Public Interest, which joined the lawsuit. 'There was an arbitrary quality to the whole thing.' Lurie said blocking scientists from studying racial disparities in public health outcomes will hurt all Americans, not just the people in the affected groups. 'A very high question for American public health is why these racial disparities continue to exist,' Lurie said. 'We all lose in terms of questions not asked, answers not generated, and opportunities for saving lives not implemented.' The Trump administration is not backing down from its stance on DEI, even as it restores the funding. The reinstatement letters from the NIH sent to scientists this month include a condition that they must comply with Trump's executive order on 'biological truth,' which rescinded federal recognition of transgender identity, along with Title VI of the Civil Rights Act of 1964, which prohibits discrimination based on race, color and national origin. Kenneth Parreno, an attorney for the plaintiffs, said he was told by Trump administration lawyers that new letters would be sent out without those terms. But Andrew Nixon, a spokesperson for the Department of Health and Human Services, said Wednesday the administration 'stands by its decision to end funding for research that prioritized ideological agendas over scientific rigor and meaningful outcomes for the American people.' Advertisement 'HHS is committed to ensuring that taxpayer dollars support programs rooted in evidence-based practices and gold standard science — not driven by divisive DEI mandates or gender ideology," Nixon said in any email to the Globe. The Trump administration's appeal is pending before the First Circuit Court of Appeals in Boston. A motion for a stay of Young's decision was denied, and the Trump administration is appealing that ruling to the US Supreme Court. The ongoing push to remove DEI from science has created fear in the scientific community, which relies on federal funding to conduct its research and make payroll. 'Scientific morale has taken a big hit,' Nunn said. 'People are apprehensive.' Indeed, major research institutions have faced mass funding cuts from the federal government since Trump took office. Brown University, the largest research institution in Rhode Island, had more than $500 million frozen until it In exchange for the research dollars to be released, Brown agreed not to engage in racial discrimination in admissions or university programming, and will provide access to admissions data to the federal government so it can assess compliance. The university also agreed not to perform any gender-affirming surgeries and to adopt Trump's definitions of a male and female in the 'biological truth' executive order. While some have avoided speaking out, fearing further funding cuts, Nunn said she felt a 'moral and ethical duty' to do so. Advertisement 'We have to dissent,' Nunn said. 'Scientific discovery around the world hangs in the balance.' Steph Machado can be reached at
